184 related articles for article (PubMed ID: 2965231)
21. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with long-term nitrendipine treatment in essential hypertension.
Tourkantonis A; Lasaridis A; Settas L
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
[TBL] [Abstract][Full Text] [Related]
23. One year experience of elderly hypertensive patients with isradipine therapy.
Stein GH; Hamilton BP; Hamilton JH; Holtzman JL; Kirkendall WM; Abrams A; Neri G; Culter R; Matthews K
J Hum Hypertens; 1994 Dec; 8(12):911-6. PubMed ID: 7884790
[TBL] [Abstract][Full Text] [Related]
24. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
[TBL] [Abstract][Full Text] [Related]
25. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
[TBL] [Abstract][Full Text] [Related]
27. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
[TBL] [Abstract][Full Text] [Related]
29. [Multicenter study of isradipine in the treatment of hypertension].
Widimský J; Dzúrik R; Fet'kovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Vnitr Lek; 1992 Apr; 38(4):317-25. PubMed ID: 1352927
[TBL] [Abstract][Full Text] [Related]
30. Muzolimine and nitrendipine in the treatment of arterial hypertension.
de Divitiis O; Di Somma S; Petitto M; Galderisi M; Iacono C; Fazio S
Z Kardiol; 1985; 74 Suppl 2():60-5. PubMed ID: 3159163
[TBL] [Abstract][Full Text] [Related]
31. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
32. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
[TBL] [Abstract][Full Text] [Related]
33. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
34. Effects of sustained-release isradipine on blood pressure and peripheral hemodynamics in hypertensive patients.
Arosio E; Pancera P; Priante F; Ribul M; De Marchi S; Lechi A
Clin Ther; 1993; 15(4):705-13. PubMed ID: 8221821
[TBL] [Abstract][Full Text] [Related]
35. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
37. Effects of calcium channel blockers on cardiovascular responses to smoking in normotensive and hypertensive smokers.
Fogari R; Zoppi A; Malamani GD; Corradi L
Int J Clin Pharmacol Res; 1992; 12(2):81-8. PubMed ID: 1428302
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive effect of bopindolol: a multi-centre study.
Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
[TBL] [Abstract][Full Text] [Related]
39. MIS (Multicentric Isradipine Study of antihypertensive therapy).
Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
